These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9785058)

  • 21. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Most significant reduction of cardiovascular events in patients undergoing lipoproteinapheresis due to raised Lp(a) levels - A multicenter observational study.
    Schatz U; Tselmin S; Müller G; Julius U; Hohenstein B; Fischer S; Bornstein SR
    Atheroscler Suppl; 2017 Nov; 30():246-252. PubMed ID: 29096845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hyperlipoproteinaemia and dyslipoproteinaemia I. Classification, diagnostics, cardiovascular, cardiometabolic and residual risk].
    Ceska R; Kvasilová M; Procházková R; Smelková G; Vrablík M
    Vnitr Lek; 2010 Jun; 56(6):526-31. PubMed ID: 20681465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a moderate fat diet with and without avocados on lipoprotein particle number, size and subclasses in overweight and obese adults: a randomized, controlled trial.
    Wang L; Bordi PL; Fleming JA; Hill AM; Kris-Etherton PM
    J Am Heart Assoc; 2015 Jan; 4(1):e001355. PubMed ID: 25567051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: seven-year results of the Dietary Intervention Study in Children (DISC).
    Obarzanek E; Kimm SY; Barton BA; Van Horn L L; Kwiterovich PO; Simons-Morton DG; Hunsberger SA; Lasser NL; Robson AM; Franklin FA; Lauer RM; Stevens VJ; Friedman LA; Dorgan JF; Greenlick MR;
    Pediatrics; 2001 Feb; 107(2):256-64. PubMed ID: 11158455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1).
    Azizi F; Rahmani M; Emami H; Mirmiran P; Hajipour R; Madjid M; Ghanbili J; Ghanbarian A; Mehrabi Y; Saadat N; Salehi P; Mortazavi N; Heydarian P; Sarbazi N; Allahverdian S; Saadati N; Ainy E; Moeini S
    Soz Praventivmed; 2002; 47(6):408-26. PubMed ID: 12643001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recognition and management of dyslipidemia in children and adolescents.
    Kwiterovich PO
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4200-9. PubMed ID: 18697860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
    LaRosa JC
    Womens Health Issues; 1992; 2(2):102-11; discussion 111-3. PubMed ID: 1617306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia-target attainment requires further increase of intensity.
    Klaus G; Taylan C; Büscher R; Schmitt CP; Pape L; Oh J; Driemeyer J; Galiano M; König J; Schürfeld C; Spitthöver R; Schaefer JR; Weber LT; Heibges A; Klingel R
    Pediatr Nephrol; 2018 Jul; 33(7):1199-1208. PubMed ID: 29502162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening programme for hyperlipidemia in children and adolescents. Prophylactic aspects of atherosclerosis.
    Radomyska B
    Med Wieku Rozwoj; 2001; 5(1):27-34. PubMed ID: 11276501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Actual situation of lipoprotein apheresis in Saxony in 2013.
    Emmrich U; Hohenstein B; Julius U
    Atheroscler Suppl; 2015 May; 18():215-25. PubMed ID: 25936329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2017 Taiwan lipid guidelines for high risk patients.
    Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
    J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Achieving National Cholesterol Education Program goals for low-density lipoprotein cholesterol in cardiac patients: importance of diet, exercise, weight control, and drug therapy.
    Allison TG; Squires RW; Johnson BD; Gau GT
    Mayo Clin Proc; 1999 May; 74(5):466-73. PubMed ID: 10319076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Obese children lipid profile: effects of hypocaloric diet and aerobic physical exercise].
    Parente EB; Guazzelli I; Ribeiro MM; Silva AG; Halpern A; Villares SM
    Arq Bras Endocrinol Metabol; 2006 Jun; 50(3):499-504. PubMed ID: 16936991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoprotein apheresis--more than just cholesterol reduction?
    Neumann CL; Schulz EG; Hagenah GC; Platzer U; Wieland E; Schettler V
    Atheroscler Suppl; 2013 Jan; 14(1):29-32. PubMed ID: 23357137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treating patients with documented atherosclerosis to National Cholesterol Education Program-recommended low-density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatin.
    Brown AS; Bakker-Arkema RG; Yellen L; Henley RW; Guthrie R; Campbell CF; Koren M; Woo W; McLain R; Black DM
    J Am Coll Cardiol; 1998 Sep; 32(3):665-72. PubMed ID: 9741509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a).
    Grützmacher P; Öhm B; Szymczak S; Dorbath C; Brzoska M; Kleinert C
    Clin Res Cardiol Suppl; 2017 Mar; 12(Suppl 1):22-26. PubMed ID: 28233269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detailed description of the cardiovascular situation in patients who have started lipoprotein apheresis treatment.
    Schampera S; Fischer S; Weiss N; Julius U
    Atheroscler Suppl; 2015 May; 18():209-14. PubMed ID: 25936328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific Lipoprotein(a) apheresis attenuates progression of carotid intima-media thickness in coronary heart disease patients with high lipoprotein(a) levels.
    Ezhov MV; Safarova MS; Afanasieva OI; Pogorelova OA; Tripoten MI; Adamova IY; Konovalov GA; Balakhonova TV; Pokrovsky SN
    Atheroscler Suppl; 2015 May; 18():163-9. PubMed ID: 25936321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.